US Supreme Court rejects Bayer bid to nix Roundup weedkiller suits

US Supreme Court rejects Bayer bid to nix Roundup weedkiller suits

WASHINGTON, June 21 (Reuters) – The US Supreme Court on Tuesday rejected Bayer AG’s (BAYGn.DE) bid to dismiss legal claims by customers who contend its Roundup weedkiller causes cancer as the German company seeks to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower … Read more

How crypto lender Celsius stumbled on risky bank-like investments

Celsius Network logo and representations of cryptocurrencies are seen in this illustration taken, June 13, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Register now for FREE unlimited access to Reuters.com register June 15 (Reuters) – Celsius Network, the retail crypto lending platform whose liquidity problems have felt cryptocurrencies plunging, stumbled on complex investments in the wholesale digital asset … Read more

Zero-COVID, big money: China’s anti-virus spending boosts medical, tech, construction

BEIJING, May 30 (Reuters) – China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy, but it has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate … Read more

Exclusive: Danone ramps up US baby formula shipments to address shortage

LONDON/LOS ANGELES, May 20 (Reuters) – Aptamil maker Danone SA (DANO.PA) has stepped up shipments of infant formula from Europe to address a shortage in the United States, according to US customs data and an analysis of ocean cargo data by shipping consultancy Ocean Audit for Reuters. Danone, the world’s second biggest baby milk formula … Read more

The US COVID-19 cases rise, so does demand for antivirals

Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in a box, at Misericordia hospital in Grosseto, Italy, February 8, 2022. REUTERS/Jennifer Lorenzini/File Photo Register now for FREE unlimited access to Reuters.com register WASHINGTON, May 17 (Reuters) – Rising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc’s (PFE.N) oral antiviral treatment Paxlovid … Read more